AU7073096A - Inhibited biological degradation of oligodeoxynucleotides - Google Patents

Inhibited biological degradation of oligodeoxynucleotides

Info

Publication number
AU7073096A
AU7073096A AU70730/96A AU7073096A AU7073096A AU 7073096 A AU7073096 A AU 7073096A AU 70730/96 A AU70730/96 A AU 70730/96A AU 7073096 A AU7073096 A AU 7073096A AU 7073096 A AU7073096 A AU 7073096A
Authority
AU
Australia
Prior art keywords
oligodeoxynucleotides
biological degradation
inhibited biological
inhibited
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70730/96A
Inventor
Joan C. Politz
Robert H Singer
Krishan L Taneja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Massachusetts UMass
Original Assignee
University of Massachusetts UMass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Massachusetts UMass filed Critical University of Massachusetts UMass
Publication of AU7073096A publication Critical patent/AU7073096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU70730/96A 1995-09-19 1996-09-16 Inhibited biological degradation of oligodeoxynucleotides Abandoned AU7073096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52998495A 1995-09-19 1995-09-19
US529984 1995-09-19
PCT/US1996/014812 WO1997011085A1 (en) 1995-09-19 1996-09-16 Inhibited biological degradation of oligodeoxynucleotides

Publications (1)

Publication Number Publication Date
AU7073096A true AU7073096A (en) 1997-04-09

Family

ID=24111991

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70730/96A Abandoned AU7073096A (en) 1995-09-19 1996-09-16 Inhibited biological degradation of oligodeoxynucleotides

Country Status (2)

Country Link
AU (1) AU7073096A (en)
WO (1) WO1997011085A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8916098A (en) * 1997-08-22 1999-03-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Polynucleotide inhibition of rna destabilization and sequestration
EP2292771A3 (en) * 1997-09-19 2011-07-27 Life Technologies Corporation Sense mRNA therapy
EP1892299A3 (en) * 1997-09-19 2011-07-20 Life Technologies Corporation Sense mRNA therapy
ATE443133T1 (en) 2002-02-01 2009-10-15 Life Technologies Corp OLIGONUCLEOTIDE COMPOSITIONS WITH IMPROVED EFFICIENCY
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
EP2600901B1 (en) 2010-08-06 2019-03-27 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
CN104531671A (en) 2010-10-01 2015-04-22 现代治疗公司 Engineered nucleic acids and methods of use thereof
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP3682905B1 (en) 2011-10-03 2021-12-01 ModernaTX, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
ES2923757T3 (en) 2011-12-16 2022-09-30 Modernatx Inc Modified mRNA compositions
AU2013243953A1 (en) 2012-04-02 2014-10-30 Modernatx, Inc. Modified polynucleotides for the production of nuclear proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
DK3539666T3 (en) 2012-05-24 2021-09-13 Univ Utah Res Found DEVICE FOR EXTREME PCR
DK2922554T3 (en) 2012-11-26 2022-05-23 Modernatx Inc Terminalt modificeret rna
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
WO2015051214A1 (en) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
WO2017079636A1 (en) * 2015-11-05 2017-05-11 University Of Utah Research Foundation Extreme reverse transcription pcr
GB201812192D0 (en) 2018-07-26 2018-09-12 Ttp Plc Variable temperature reactor, heater and control circuit for the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264423A (en) * 1987-03-25 1993-11-23 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products

Also Published As

Publication number Publication date
WO1997011085A1 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
AU7073096A (en) Inhibited biological degradation of oligodeoxynucleotides
AU5393796A (en) Bioreactor
AU6602196A (en) Electrode catheter
AU4786496A (en) New forms of paroxetin hydrochloride
AU1023797A (en) Reduction of hair growth
AU5178196A (en) Reduction of hair growth
AU5441896A (en) Cooperative oligonucleotides
AUPN271295A0 (en) Method of treatment
AU5486596A (en) Surgical method
AU7604096A (en) Gameboard
AU3555295A (en) Game of chance
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU7318396A (en) Methods of preserving microorganisms
AU3126595A (en) Antisense oligonucleotides of pleiotrophin
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU8817398A (en) Method of drug selection
AU6829696A (en) Treatment of solutions
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
AUPN271195A0 (en) Method of selecting livestock
AU1093697A (en) Active bio-compounds
AU7004096A (en) Syringe
AU7504196A (en) Body support
AU7573296A (en) Bandage
AU7704796A (en) Syringe